Gsid, established in 2006, is a global solutions provider for infectious diseases based in South San Francisco, CA. With a focus on research and development, the company is dedicated to finding innovative solutions to combat infectious diseases worldwide.
As a leader in the field, Gsid has gained recognition for its clinical trial, PrEPVacc, which has been featured on CNN International. With a commitment to global health, the company strives to make a significant impact in the fight against infectious diseases through its cutting-edge research and development efforts.
Generated from the website